Bioderm Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bioderm Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6439
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bioderm Inc (Bioderm) is a medical equipment company that manufactures designs, and markets hydrocolloid products. The company manufactures hydrocolloid products for urinary management, securement, infection control, and skin protection. Its products include cathgrip, bioplus+, freederm, men’s liberty, safe n’ dry, and penile clamp, among others. Bioderm’s cathgrip is a catheter securement system; safe n’ dry is a male external catheter for institutional and hospital use, and men’s liberty is a male external catheter designed for community dwelling men. The company supplies its products for applications such as infection control, urinary management, and skin protection. Bioderm headquartered in Largo, Florida, the US.

Bioderm Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bioderm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bioderm Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bioderm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bioderm Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Bioderm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bioderm Inc, Medical Equipment, Deal Details 10
Venture Financing 10
BioDerm to Raise USD4.8 Million in Venture Financing 10
BioDerm to Raise USD2 Million in Venture Financing 11
Partnerships 12
Medline Industries Expands Distribution Partnership Agreement with BioDerm 12
Bioderm Enters into Distribution Agreement with Medline 13
CellMark Enters into Agreement with BioDerm 14
Bioderm Inc – Key Competitors 15
Bioderm Inc – Key Employees 16
Bioderm Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Jul 05, 2017: Rachel Scharfman Joins BioDerm as Vice President of Sales & Marketing 18
Jul 05, 2017: Rachel Scharfman Joins BioDerm as Vice President of Sales & Marketing 19
Other Significant Developments 20
Dec 06, 2017: BioDerm Awards Medline Exclusive Distribution Agreement 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Bioderm Inc, Medical Equipment, Key Facts 2
Bioderm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bioderm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bioderm Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bioderm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bioderm Inc, Deals By Market, 2012 to YTD 2018 8
Bioderm Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioDerm to Raise USD4.8 Million in Venture Financing 10
BioDerm to Raise USD2 Million in Venture Financing 11
Medline Industries Expands Distribution Partnership Agreement with BioDerm 12
Bioderm Enters into Distribution Agreement with Medline 13
CellMark Enters into Agreement with BioDerm 14
Bioderm Inc, Key Competitors 15
Bioderm Inc, Key Employees 16

List of Figures
Bioderm Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bioderm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bioderm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bioderm Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bioderm Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bioderm Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Bioderm Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bioderm Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Bioderm Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shionogi Inc:企業の戦略的SWOT分析
    Shionogi Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Blueberry Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Blueberry Therapeutics Ltd (Blueberry Therapeutics) is a provider of nano medicines for the treatment of dermatological disorders. Its pipeline product portfolio includes BB2603-NCE, developed to treat onychomycosis and associated tinea pedis; BB2312 used for the treatment of Acne diseases, …
  • GOBARTO S.A.:戦略・SWOT・企業財務分析
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Karo Pharma AB (KARO):製薬・医療:M&Aディール及び事業提携情報
    Summary Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new phar …
  • Ortivus AB (ORTI B):企業の財務・戦略的SWOT分析
    Summary Ortivus AB (Ortivus) is a supplier of mobile solutions for emergency medical care. The company develops and offers cardiology, and mobile monitoring and communication solutions. Its products include MobiMed Smart, CoroNet, excense heart record system and excense decision support healthcare s …
  • EnWave Corp (ENW):企業の財務・戦略的SWOT分析
    EnWave Corp (ENW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Haemonetics Corp (HAE):医療機器:M&Aディール及び事業提携情報
    Summary Haemonetics Corp (Haemonetics) is a healthcare company that offers blood management technologies and software solutions. Its portfolio includes integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehensive suite o …
  • MaxCyte Inc (MXCT):企業の財務・戦略的SWOT分析
    Summary MaxCyte Inc (MaxCyte) is a biotherapeutic company that conducts research and develops cell transfection technologies. The company offers MaxCyte STX, MaxCyte VLX and MaxCyte GT instruments. It utilizes flow electroporation technology for discovery, development and manufacturing of cell-based …
  • Alawwal Bank:企業の戦略・SWOT・財務情報
    Alawwal Bank - Strategy, SWOT and Corporate Finance Report Summary Alawwal Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Software AG (SOW):企業の財務・戦略的SWOT分析
    Summary Software AG (SAG) is a technology company that provides software management solutions. The company offers digital business platform with integration, process management, adaptive application development, real-time analytics and enterprise architecture management. Its products include Adabas …
  • Bsquare Corporation (BSQR):企業の財務・戦略的SWOT分析
    Bsquare Corporation (BSQR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Angion Biomedica Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Angion Biomedica Corp (Angion) is a clinical-stage organ restoration biopharmaceutical company that discovers and develops novel treatments for the treatment of renal and chronic organ injury and disease. The company’s pipeline products include BB3, ANG-3070, ANG-3586, ANG-4201, TBD and ANG- …
  • Didi Chuxing Co Ltd:企業の戦略的SWOT分析
    Didi Chuxing Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Duke Energy Corporation:発電所・企業SWOT分析
    Duke Energy Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Vetoquinol SA (VETO):企業の財務・戦略的SWOT分析
    Summary Vetoquinol SA (Vetoquinol) is a veterinary pharmaceutical company that develops, produces and distributes veterinary drugs and non-medicinal products. The company provides pain management, anti-infective, hygiene and care, pest control, behavior, internal medicine, reproduction, behaviour an …
  • Adams Resources & Energy, Inc.:企業の戦略・SWOT・財務分析
    Adams Resources & Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Adams Resources & Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • OncoResponse Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OncoResponse Inc (OncoResponse) focuses on the discovery, development and commercialization of therapeutic antibodies for the treatment of cancer. The company’s lead program includes ONCR-201, an anti-EMP2 fully-human monoclonal antibody, which is developed for female malignancies. It utiliz …
  • Centre for Drug Design and Discovery:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution operates as an investment fund and technology transfer platform to promote the discovery and development of medicines for all kinds of diseases. It provide …
  • Caspian Sunrise Plc (CASP):石油・ガス:M&Aディール及び事業提携情報
    Summary Caspian Sunrise Plc (Caspian), formerly Roxi Petroleum plc, is an oil and gas exploration and development company. The company acquires, explores and develops crude oil. It holds interests in the exploration and production of BNG contract area in the Pre-Caspian basin and the Mangyshlak basi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆